rs774769004
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_021098.3(CACNA1H):c.6295G>A(p.Glu2099Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000139 in 1,580,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E2099D) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.6295G>A | p.Glu2099Lys | missense_variant | Exon 35 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.6310G>A | p.Glu2104Lys | missense_variant | Exon 34 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.6280G>A | p.Glu2094Lys | missense_variant | Exon 34 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.6277G>A | p.Glu2093Lys | missense_variant | Exon 34 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.6277G>A | p.Glu2093Lys | missense_variant | Exon 35 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.6262G>A | p.Glu2088Lys | missense_variant | Exon 35 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.6256G>A | p.Glu2086Lys | missense_variant | Exon 35 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.6244G>A | p.Glu2082Lys | missense_variant | Exon 34 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.6238G>A | p.Glu2080Lys | missense_variant | Exon 34 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.6188G>A | p.Arg2063Gln | missense_variant | Exon 36 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.6137G>A | p.Arg2046Gln | missense_variant | Exon 35 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.6110G>A | p.Arg2037Gln | missense_variant | Exon 36 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*2214G>A | non_coding_transcript_exon_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*1343G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*4113G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5739G>A | non_coding_transcript_exon_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*1236G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*1154G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1874G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*962G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*929G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.*209G>A | non_coding_transcript_exon_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.6295G>A | non_coding_transcript_exon_variant | Exon 35 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.6262G>A | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*1411G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711483.1 | c.*209G>A | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.*209G>A | 3_prime_UTR_variant | Exon 34 of 34 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*2214G>A | 3_prime_UTR_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*1343G>A | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*4113G>A | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5739G>A | 3_prime_UTR_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*1236G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*1154G>A | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1874G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*962G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*929G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.*209G>A | 3_prime_UTR_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*1411G>A | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000621827.2 | n.6121+174G>A | intron_variant | Intron 35 of 36 | 6 | ENSP00000518766.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 35 show subpopulations
GnomAD2 exomes AF: 0.0000145 AC: 3AN: 207340 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000126 AC: 18AN: 1428184Hom.: 0 Cov.: 73 AF XY: 0.0000113 AC XY: 8AN XY: 709576 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.6295G>A (p.E2099K) alteration is located in exon 35 (coding exon 34) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 6295, causing the glutamic acid (E) at amino acid position 2099 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at